Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Non-Current Debt (2024 - 2025)

Historic Non-Current Debt for Eton Pharmaceuticals (ETON) over the last 2 years, with Q3 2025 value amounting to $27.6 million.

  • Eton Pharmaceuticals' Non-Current Debt changed N/A to $27.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.6 million, marking a year-over-year change of. This contributed to the annual value of $29.8 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Eton Pharmaceuticals' Non-Current Debt stood at $27.6 million.
  • Eton Pharmaceuticals' Non-Current Debt's 5-year high stood at $29.8 million during Q4 2024, with a 5-year trough of $27.4 million in Q2 2025.